Global Psychedelic Drugs Market Size & Share to 2027

Psychedelic is called as psychedelics, which is class of hallucinogenic drugs including both classic hallucinogens and dissociative drugs which are used recreationally, to enhance the sensory perception, elevate the mood swings, energy level promoting spiritual experiences, and thought process. These drugs have been used experimentally for psychological treatment.

Market Drivers

Increase in prevalence of depression across the globe is the key driving factor which is expected to boost the global psychedelic drugs market growth. Furthermore, change in lifestyle and requirement for enhanced and better life quality will positively contribute the market growth. Also, increase in research and development activities is expected to propel the market growth during this analysis period. Moreover, increase in dependency on psychedelic drugs for treatment of depression is expected to propel the global psychedelic drugs market growth during this forecast period.

Market Restraints

However, stringent rules and regulations imposed by government to commercialize psychedelic drugs is the major challenging factor which is expected to hinder the global psychedelic drugs market growth. Also, poor efficiency and safety profile of existing intervention will affect the market growth over the forecast period.

Market Segmentation

Global Psychedelic Drugs Market is segmented into drug type such as Lysergic Acid Diethylamide (LSD), 3,4-MethylEnedioxyMethamphetamine (Ecstasy), Phencyclidine, Gamma Hydroxybutyric Acid (GHB), Ketamine, Ayahuasca, Salvia, Psilocybin, and Others, by route of administration such as Oral, Injectable, and Inhalation, by distribution channel such as Direct Retailers, Online Pharmacies, and Others. Further, market is segmented into End -Users such as Hospitals, Homecare, Specialty Clinics, and others.

Also, Global Psychedelic Drugs Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

Market Key Players

Various key players are discussed in this report such as AstraZeneca,, COMPASS,, Klarisana, F. Hoffmann-La Roche Ltd, Takeda Pharmaceutical Company Limited,, Dr. Reddy’s Laboratories Ltd,, Pfizer Inc,, Merck & Co., Inc, ,and Lundbeck A/S

Market Taxonomy

By Drug Type

Lysergic Acid Diethylamide (LSD)
3,4-MethylEnedioxyMethamphetamine (Ecstasy)
Phencyclidine
Gamma Hydroxybutyric Acid (GHB)
Ketamine
Ayahuasca
Salvia
Psilocybin
Others

By Route of Administration

Oral
Injectable
Inhalation

By Distribution Channel

Direct Retailers
Online Pharmacies
Others

By End-User

Hospitals
Homecare
Specialty Clinics
Others

By Region

North America
Latin America
Europe
Asia Pacific
Middle East & Africa

Key Questions Addressed by the Report

What are the Key Opportunities in Global Psychedelic Drugs Market?
What will be the growth rate from 2019 to 2027?
Which segment/region will have highest growth?
What are the factors that will impact/drive the Market?
What is the competitive Landscape in the Industry?
What is the role of key players in the value chain?
What are the strategies adopted by key players?

1 Introduction

1.1 Objective of the Study
1.2 Market Definition
1.3 Market Scope

2 Research Methodology

2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources

3 Executive Summary

4 Global Psychedelic Drugs Market Outlook

4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis

5 Global Psychedelic Drugs Market, By Drug Type

5.1 Y-o-Y Growth Comparison, By Drug Type
5.2 Global Psychedelic Drugs Market Share Analysis, By Drug Type
5.3 Global Psychedelic Drugs Market Size and Forecast, By Drug Type
5.3.1 Lysergic Acid Diethylamide (LSD)
5.3.2 3,4-MethylEnedioxyMethamphetamine (Ecstasy)
5.3.3 Phencyclidine
5.3.4 Gamma Hydroxybutyric Acid (GHB),
5.3.5 Ketamine
5.3.6 Ayahuasca
5.3.7 Salvia
5.3.8 Psilocybin
5.3.9 Others

6 Global Psychedelic Drugs Market, By Route of Administration

6.1 Y-o-Y Growth Comparison, By Route of Administration
6.2 Global Psychedelic Drugs Market Share Analysis, By Route of Administration
6.3 Global Psychedelic Drugs Market Size and Forecast, By Route of Administration
6.3.1 Oral
6.3.2 Injectable
6.3.3 Inhalation

7 Global Psychedelic Drugs Market, By Distribution Channel

7.1 Y-o-Y Growth Comparison, By Distribution Channel
7.2 Global Psychedelic Drugs Market Share Analysis, By Distribution Channel
7.3 Global Psychedelic Drugs Market Size and Forecast, By Distribution Channel
7.3.1 Direct Retailers
7.3.2 Online Pharmacies
7.3.3 Others

8 Global Psychedelic Drugs Market, By End User

8.1 Y-o-Y Growth Comparison, By End User
8.2 Global Psychedelic Drugs Market Share Analysis, By End User
8.3 Global Psychedelic Drugs Market Size and Forecast, By End User
8.3.1 Hospitals
8.3.2 Homecare
8.3.3 Speciality Clinics
8.3.4 Others

9 Global Psychedelic Drugs Market, By Region

9.1 Global Psychedelic Drugs Market Share Analysis, By Region
9.2 Global Psychedelic Drugs Market Share Analysis, By Region
9.3 Global Psychedelic Drugs Market Size and Forecast, By Region

10 North America Psychedelic Drugs Analysis and Forecast (2020 - 2027)

10.1 Introduction
10.2 North America Psychedelic Drugs Product Market Share Analysis, By Drug Type
10.3 North America Psychedelic Drugs Product Market Size and Forecast, By Route of Administration
10.4 North America Psychedelic Drugs Product Market Size and Forecast, By Distribution Channel
10.5 North America Psychedelic Drugs Product Market Size and Forecast, By End User
10.6 North America Psychedelic Drugs Product Market Size and Forecast, By Country
10.6.1 U.S.
10.6.2 Canada
10.6.3 Mexico

11 Europe Psychedelic Drugs Market Analysis and Forecast (2020 - 2027)

11.1 Introduction
11.2 Europe Psychedelic Drugs Product Market Share Analysis, By Drug Type
11.3 Europe Psychedelic Drugs Product Market Size and Forecast, By Route of Administration
11.4 Europe Psychedelic Drugs Product Market Size and Forecast, By Distribution Channel
11.5 Europe Psychedelic Drugs Product Market Size and Forecast, By End User
11.6 Europe Psychedelic Drugs Product Market Size and Forecast, By Country
11.6.1 Germany
11.6.2 France
11.6.3 UK
11.6.4 Rest of Europe

12 Asia Pacific Psychedelic Drugs Market Analysis and Forecast (2020 - 2027)

12.1 Introduction
12.2 Asia Pacific Psychedelic Drugs Product Market Share Analysis, By Drug Type
12.3 Asia Pacific Psychedelic Drugs Product Market Size and Forecast, By Route of Administration
12.4 Asia Pacific Psychedelic Drugs Product Market Size and Forecast, By Distribution Channel
12.5 Asia Pacific Psychedelic Drugs Product Market Size and Forecast, By End User
12.6 Asia Pacific Psychedelic Drugs Product Market Size and Forecast, By Country
12.6.1 China
12.6.2 Japan
12.6.3 India
12.6.4. Rest of Asia Pacific

13 Latin America Psychedelic Drugs Market Analysis and Forecast (2020 - 2027)

13.1 Introduction
13.2 Latin America Psychedelic Drugs Product Market Share Analysis, By Drug Type
13.3 Latin America Psychedelic Drugs Product Market Size and Forecast, By Route of Administration
13.4 Latin America Psychedelic Drugs Product Market Size and Forecast, By Distribution Channel
13.5 Latin America Psychedelic Drugs Product Market Size and Forecast, By End User
13.6 Latin America Psychedelic Drugs Product Market Size and Forecast, By Country

14 Middle East Psychedelic Drugs Market Analysis and Forecast (2020 - 2027)

14.1 Introduction
14.2 Middle East Psychedelic Drugs Product Market Share Analysis, By Drug Type
14.3 Middle East Psychedelic Drugs Product Market Size and Forecast, By Route of Administration
14.4 Middle East Psychedelic Drugs Product Market Size and Forecast, By Distribution Channel
14.5 Middle East Psychedelic Drugs Product Market Size and Forecast, By End User
14.6 Middle East Psychedelic Drugs Product Market Size and Forecast, By Country

15 Competitive Analysis

15.1 Competition Dashboard
15.2 Market share Analysis of Top Vendors
15.3 Key Development Strategies

16 Company Profiles

16.1 AstraZeneca
16.1.1 Overview
16.1.2 Offerings
16.1.3 Key Financials
16.1.4 Business Segment & Geographic Overview
16.1.5 Key Market Developments
16.1.6 Key Strategies
16.2 COMPASS
16.2.1 Overview
16.2.2 Offerings
16.2.3 Key Financials
16.2.4 Business Segment & Geographic Overview
16.2.5 Key Market Developments
16.2.6 Key Strategies
16.3 Klarisana
16.3.1 Overview
16.3.2 Offerings
16.3.3 Key Financials
16.3.4 Business Segment & Geographic Overview
16.3.5 Key Market Developments
16.3.6 Key Strategies
16.4 F. Hoffmann-La Roche Ltd
16.4.1 Overview
16.4.2 Offerings
16.4.3 Key Financials
16.4.4 Business Segment & Geographic Overview
16.4.5 Key Market Developments
16.4.6 Key Strategies
16.5 Takeda Pharmaceutical Company Limited
16.5.1 Overview
16.5.2 Offerings
16.5.3 Key Financials
16.5.4 Business Segment & Geographic Overview
16.5.5 Key Market Developments
16.5.6 Key Strategies
16.6 Dr. Reddy’s Laboratories Ltd
16.6.1 Overview
16.6.2 Offerings
16.6.3 Key Financials
16.6.4 Business Segment & Geographic Overview
16.6.5 Key Market Developments
16.6.6 Key Strategies
16.7 Pfizer Inc
16.7.1 Overview
16.7.2 Offerings
16.7.3 Key Financials
16.7.4 Business Segment & Geographic Overview
16.7.5 Key Market Developments
16.7.6 Key Strategies
16.8 Merck & Co., Inc
16.8.1 Overview
16.8.2 Offerings
16.8.3 Key Financials
16.8.4 Business Segment & Geographic Overview
16.8.5 Key Market Developments
16.8.6 Key Strategies
16.9 Lundbeck A/S
16.9.1 Overview
16.9.2 Offerings
16.9.3 Key Financials
16.9.4 Business Segment & Geographic Overview
16.9.5 Key Market Developments
16.9.6 Key Strategies